3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
36
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Burkitt Lymphoma
7
Neoplasms
6
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Leukemia
6
Lymphoma, B-Cell
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Neoplasm Metastasis
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Pain
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Lymphatic Diseases
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Neoplasms
2
Hematologic Diseases
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumours
1
Sezary Syndrome
1
Interventions
enzalutamide
2
cabazitaxel
1
Prednisone
1
Positron Emission Tomography Computed Tomography
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostate Cancer Metastatic
×
Prednisone
×
Clear all
NCT02379390
2019-06-21
PRIMCAB
Sanofi
Phase 2
Terminated
8 enrolled
8 charts